MRNA
Moderna, Inc. Common Stock
$55.63 ▲ +3.27% Biological Products, (No Diagnostic Substances) $21.5B
59/100
BUY
5-factor composite · bullish read
Technical62
Momentum66
Fundamental32
Options34
Microstructure59
✓ Verified Track Record
53% win rate across 939 resolved signals — every QuantLogix signal is logged at issuance and graded against live market outcomes.

QuantLogix's 5-factor engine currently reads Moderna, Inc. Common Stock (MRNA) as a buy at 59/100 — a bullish setup. Momentum is the strongest leg at 66/100, while fundamental lags at 32/100. MRNA trades in the Biological Products, (No Diagnostic Substances) sector with a $21.5B market cap.

Live 5-factor quant signal — technical, momentum, fundamental, options, and microstructure — recomputed every few minutes. Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. See the verified track record → · Browse all signal scorecards →

Link copied